)
Beam Therapeutics (BEAM) investor relations material
Beam Therapeutics AGM 2026 summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Opening remarks and agenda
CEO welcomed attendees and highlighted the benefits of a virtual meeting format for inclusivity and efficiency.
Attendees were introduced to the board members and the independent auditor from Deloitte.
The agenda and rules of procedure were made available to shareholders via the web portal.
Board and executive committee updates
Three Class III directors—John Evans, John Maraganore, and Christi Shaw—were nominated for terms ending in 2029.
Shareholder proposals
Three proposals were presented: election of directors, ratification of Deloitte as auditor, and advisory approval of executive compensation.
The board recommended voting in favor of all proposals.
- Lead gene editing programs advance toward approval with strong efficacy, safety, and payer value.BEAM
RBC Capital Markets Global Healthcare Conference 202620 May 2026 - Revenue and clinical milestones surged, net loss narrowed, and cash runway extends to mid-2029.BEAM
Q1 20267 May 2026 - Single-dose BEAM-302 at 60 mg delivers durable, functional AAT restoration and strong safety in AATD.BEAM
Study result26 Apr 2026 - Votes include director elections, auditor ratification, and executive pay approval for 2026.BEAM
Proxy filing17 Apr 2026 - Director elections, auditor ratification, and executive pay are up for shareholder approval.BEAM
Proxy filing17 Apr 2026 - BEAM-304 for PKU, $500M financing, and strong Q4 net income drive pipeline and cash runway into 2029.BEAM
Q4 202524 Feb 2026 - Base editing platform delivers robust clinical results and pipeline growth, with key 2025 milestones ahead.BEAM
H.C. Wainwright 27th Annual Global Investment Conference3 Feb 2026 - Pivotal sickle cell trial advances and first AAT patient dosing set for this month in the UK.BEAM
Jefferies 2024 Global Healthcare Conference1 Feb 2026 - Q3 net loss $96.7M; $925.8M cash supports pipeline milestones and runway into 2027.BEAM
Q3 202416 Jan 2026
Next Beam Therapeutics earnings date
Next Beam Therapeutics earnings date
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
Frequently asked questions
Explore our global coverage
)
)